anemia造句

What is iron-deficiency anemia?

Is my anemia likely temporary or chronic?

There are many different types of anemia.

There are different types of anemia, and treatment varies.

See your doctor if you suspect you have anemia, because anemia can be a sign of serious illnesses.

In some kinds of anemia, there are low amounts of all three types of blood cells.

Family history. If your family has a history of an inherited anemia, such as sickle cell anemia, you also may be at increased risk of the condition.

An abnormally large red blood cell, especially one associated with pernicious anemia.

The number of red cells is usually less than normal, resulting in anemia.

Interference with the normal production of heme or globin leads to anemia.

There are many forms of anemia, each with its own cause.

"I am all right, it is just a serious case of anemia. Believe me, my parents told me that".

"The effects of being iron deficient not only cause anemia, but may also cause" long-term, irreversible effects on children's cognitive and behavioral development.

Diagnostic procedures of iron deficiency anemia, low-oxygen-partial-pressure cabin environment and hemoglobin standard of flight attendants are also to be discussed.

Inherited deficiency of pyruvate kinase, a key glycolytic enzyme, causes ATP deficiency, which leads to reduced RBC life span and hemolytic anemia.

The three major causes of anemia are blood loss, decreased production of red blood cells, or increased destruction of red blood cells, as previously mentioned.

A trained midwife could have given her a deworming pill and iron supplements early in the pregnancy, addressing that anemia and strengthening her.

This image shows two red blood cells: a normal red blood cell (colored red in the background) and a red blood cell affected by sickle-cell anemia (in the foreground).

In APL, there is a drop in the production of normal red blood cells and platelets, resulting in anemia and thrombocytopenia. The bone marrow is unable to produce healthy red blood cells.

The decision is a reprieve for Amgen, which is already facing declining sales of its anemia drugs because of safety concerns and a resulting cutback in reimbursement by Medicare.